| 1 |
Mehal WZ, Lo YM, Wordsworth BP, et al.HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis[J]. Gastroenterology, 1994, 106(1): 160-167.
|
| 2 |
Yoshizawa K, Umemura T, Ota M. Genetic background of autoimmune hepatitis in Japan[J]. J Gastroenterol, 2011, 46 Suppl 1: 42-47.
|
| 3 |
Duarte-Rey C, Pardo AL, Rodríguez-Velosa Y, et al.HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis[J]. Autoimmun Rev, 2009, 8(4): 325-331.
|
| 4 |
Li M, Zheng H, Tian QB, et al.HLA-DR polymorphism and primary biliary cirrhosis: evidence from a meta-analysis[J]. Arch Med Res, 2014, 45(3): 270-279.
|
| 5 |
刘海英，范列英，屠小卿，等．肺炎衣原体感染与原发性胆汁性肝硬化的相关性研究[J]．中华肝脏病杂志，2004，12(9)：546-548.
|
| 6 |
Invernizzi P, Battezzati PM, Crosignani A, et al.Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis[J]. J Hepatol, 2003, 38(4): 401-406.
|
| 7 |
de Boer YS, van Gerven NM, Zwiers A, et al.Genome-wide association study identifies variants associated with autoimmune hepatitis type 1[J]. Gastroenterology, 2014, 147(2): 443-452.
|
| 8 |
Gulamhusein AF, Juran BD, Lazaridis KN.Genome-Wide Association Studies in Primary Biliary Cirrhosis[J]. Semin Liver Dis, 2015, 35(4): 392-401.
|
| 9 |
Bianchi I, Carbone M, Lleo A, et al.Genetics and epigenetics of primary biliary cirrhosis[J]. Semin Liver Dis, 2014, 34(3): 255-264.
|
| 10 |
Liu JZ, Hov JR, Folseraas T, et al.Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis[J]. Nat Genet, 2013, 45(6): 670-675.
|
| 11 |
Li S, Huang X, Zhong H, et al.Tumour necrosis factor alpha(TNF-α)genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis[J]. J Genet, 2013, 92(3): 617-628.
|
| 12 |
Chow IT, James EA, Gates TJ, et al.Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08: 01 and DRB1*11: 01 Is predicted by their structural motifs and correlates with disease risk[J]. J Immunol, 2013, 190(9): 4516-4524.
|
| 13 |
Roggenbuck D, Mytilinaiou MG, Lapin SV, et al.Asialoglycoprotein receptor(ASGPR): a peculiar target of liver-specific autoimmunity[J]. Auto Immun Highlights, 2012, 3(3): 119-125.
|
| 14 |
Wies I, Brunner S, Henninger J, et al.Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis[J]. Lancet, 2000, 355(9214): 1510-1515.
|
| 15 |
Christen U, Holdener M, Hintermann E. Cytochrome P450 2D6 as a model antigen[J]. Dig Dis, 2010, 28(1): 80-85.
|
| 16 |
Wang J, Yang G, Dubrovsky AM, et al, Xenobiotics and loss of tolerance in primary biliary cholangitis[J]. World J Gastroenterol, 2016, 22(1): 338-348.
|
| 17 |
Aleksandar Arsenijevic, Jelena Milovanovic, Bojana Stojanovic, et al.Xenobiotic induced model of primary biliary cirrhosis[J]. Ser J Exp Clin Res, 2014, 15(3): 145-150.
|
| 18 |
Karlsen TH, Vesterhus M, Boberg KM.Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis[J]. Aliment Pharmacol Ther, 2014, 39(3): 282-301.
|
| 19 |
McLean F. Clinical significance of autoantibodies directed against nuclear and cytoplasmic antigens in autoimmune liver disease[J]. Br J Biomed Sci, 2013, 70(1): 10-14.
|
| 20 |
Rong G, Zhou Y, Xiong Y, et al.Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population[J]. Clin Exp Immunol, 2009, 156(2): 217-225.
|
| 21 |
Ferri S, Longhi MS, De Molo C. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis[J]. Hepatology, 2010, 52(3): 999-1007.
|
| 22 |
Peiseler M, Sebode M, Franke B, et al.FOXP3＋ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency[J]. J Hepatol, 2012, 57(1): 125-132.
|
| 23 |
Longhi MS, Ma Y, Mieli-Vergani G, et al.Regulatory T cells in autoimmune hepatitis[J]. J Hepatol, 2012, 57(4): 932-933.
|
| 24 |
Sebode M, Peiseler M, Franke B, et al.Reduced FOXP3＋ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms[J]. J Hepatol, 2014, 60(5): 1010-1016.
|
| 25 |
Zhao L, Tang Y, You Z, et al.Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression[J]. PLoS One, 2011, 6(4): e18909.
|
| 26 |
Fenoglio D, Bernuzzi F, Battaglia F, et al.Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases[J]. Autoimmun Rev, 2012, 12(2): 300-304.
|
| 27 |
Katt J, Schwinge D, Schoknecht T, et al.Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis[J]. Hepatology, 2013, 58(3): 1084-1093.
|